Literature DB >> 12354290

Mixed lineage kinase 3 mediates gp120IIIB-induced neurotoxicity.

Amos Bodner1, Anna C Maroney, James P Finn, Ghanashyam Ghadge, Raymond Roos, Richard J Miller.   

Abstract

Overexpression of gp120, the major coat protein of the HIV-1 virus, in central glial cells, or treatment of neurons with gp120 in culture, produces apoptotic neuronal death. Here we demonstrate that CEP-1347 (KT7515), an inhibitor of mixed lineage kinase 3 (MLK3), an upstream activator of JNK, inhibits gp120IIIB-induced apoptosis of hippocampal neurons. Furthermore, expression of wild type MLK3 in hippocampal pyramidal neurons enhanced gp120IIIB-induced neurotoxicity, whereas expression of a dominant negative MLK3 protected neurons from the toxic effects of the glycoprotein. These results indicate a role for MLK3 signaling in gp120IIIB-induced neuronal death, and suggest potential clinical utility of CEP-1347 in inhibiting the progression of AIDS dementia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12354290     DOI: 10.1046/j.1471-4159.2002.01088.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  17 in total

1.  Differential involvement of p38 and JNK MAP kinases in HIV-1 Tat and gp120-induced apoptosis and neurite degeneration in striatal neurons.

Authors:  I N Singh; N El-Hage; M E Campbell; S E Lutz; P E Knapp; A Nath; K F Hauser
Journal:  Neuroscience       Date:  2005-08-19       Impact factor: 3.590

Review 2.  Chemokines: integrators of pain and inflammation.

Authors:  Fletcher A White; Sonia K Bhangoo; Richard J Miller
Journal:  Nat Rev Drug Discov       Date:  2005-10       Impact factor: 84.694

3.  GCP II inhibition rescues neurons from gp120IIIB-induced neurotoxicity.

Authors:  Ajit G Thomas; Amos Bodner; Ghanashyam Ghadge; Raymond P Roos; Barbara S Slusher
Journal:  J Neurovirol       Date:  2009-09       Impact factor: 2.643

4.  Mixed lineage kinase-3 stabilizes and functionally cooperates with TRIBBLES-3 to compromise mitochondrial integrity in cytokine-induced death of pancreatic beta cells.

Authors:  Rohan K Humphrey; Christina J Newcomb; Shu-Mei A Yu; Ergeng Hao; Doris Yu; Stan Krajewski; Keyong Du; Ulupi S Jhala
Journal:  J Biol Chem       Date:  2010-04-26       Impact factor: 5.157

Review 5.  Broad Spectrum Mixed Lineage Kinase Type 3 Inhibition and HIV-1 Persistence in Macrophages.

Authors:  Priyanka Saminathan; Bhavesh D Kevadiya; Daniel F Marker; Howard E Gendelman; Santhi Gorantla; Harris A Gelbard
Journal:  J Neuroimmune Pharmacol       Date:  2019-01-07       Impact factor: 4.147

Review 6.  Rebuilding synaptic architecture in HIV-1 associated neurocognitive disease: a therapeutic strategy based on modulation of mixed lineage kinase.

Authors:  Harris A Gelbard; Stephen Dewhurst; Sanjay B Maggirwar; Michelle Kiebala; Oksana Polesskaya; Howard E Gendelman
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

7.  Discovery, synthesis, and characterization of an orally bioavailable, brain penetrant inhibitor of mixed lineage kinase 3.

Authors:  Val S Goodfellow; Colin J Loweth; Satheesh B Ravula; Torsten Wiemann; Thong Nguyen; Yang Xu; Daniel E Todd; David Sheppard; Scott Pollack; Oksana Polesskaya; Daniel F Marker; Stephen Dewhurst; Harris A Gelbard
Journal:  J Med Chem       Date:  2013-10-03       Impact factor: 7.446

8.  Neuroprotective activities of CEP-1347 in models of neuroAIDS.

Authors:  Dawn Eggert; Prasanta K Dash; Santhi Gorantla; Huanyu Dou; Giovanni Schifitto; Sanjay B Maggirwar; Stephen Dewhurst; Larisa Poluektova; Harris A Gelbard; Howard E Gendelman
Journal:  J Immunol       Date:  2009-12-04       Impact factor: 5.422

9.  The new small-molecule mixed-lineage kinase 3 inhibitor URMC-099 is neuroprotective and anti-inflammatory in models of human immunodeficiency virus-associated neurocognitive disorders.

Authors:  Daniel F Marker; Marie-Ève Tremblay; Jenna M Puccini; Justin Barbieri; Mary A Gantz Marker; Colin J Loweth; E Chris Muly; Shao-Ming Lu; Val S Goodfellow; Stephen Dewhurst; Harris A Gelbard
Journal:  J Neurosci       Date:  2013-06-12       Impact factor: 6.167

10.  Pharmacokinetic interactions of CEP-1347 and atazanavir in HIV-infected patients.

Authors:  Qing Ma; Harris A Gelbard; Sanjay B Maggirwar; Stephen Dewhurst; Howard E Gendelman; Derick R Peterson; Robin DiFrancesco; Jill S Hochreiter; Gene D Morse; Giovanni Schifitto
Journal:  J Neurovirol       Date:  2013-06-05       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.